We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock

Delisted

NMRD was delisted on the 4th of January, 2024.

25 hedge funds and large institutions have $7.58M invested in Nemaura Medical, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,694% more capital invested

Capital invested by funds: $48K → $7.58M (+$7.53M)

2,200% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 1

733% more funds holding

Funds holding: 325 (+22)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
25
Holders Change
+22
Holders Change %
+733.33%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OIA
26
Optimum Investment Advisors
Illinois
-$9K -1,500 Closed

NMRD Hedge Fund Activity: Q2 2020 in Review

25 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2020, worth a combined $7.58M — up 15,694% from $48K a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new NMRD positions and 1 closed out — a net gain of 22 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $2.45M. The largest seller was UBS Group, cutting an estimated $19.4K.

  • 25 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2020, up from 3 in Q1 2020.
  • Funds reported $7.58M of Nemaura Medical, Inc. Common Stock stock for Q2 2020, up 15,694% quarter-over-quarter.
  • 23 funds opened new Nemaura Medical, Inc. Common Stock positions in Q2 2020 and 1 closed out, a net change of +22 holders.
  • The largest Nemaura Medical, Inc. Common Stock buyer in Q2 2020 was BlackRock, an estimated $2.45M added.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q2 2020 was UBS Group, an estimated $19.4K sold.

Based on aggregated 13F filings for Q2 2020.